تداخل‌های دارویی
Deferiprone + Exagamglogene autotemcel
شدت: شدید
Deferiprone and Exagamglogene autotemcel: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Iron chelators such as deferiprone can be myelosuppressive and may interfere with stem cell mobilization, conditioning and engraftment. Continuing deferiprone around these steps raises the risk of delayed hematologic recovery and infection.
معنای این تداخل به زبان ساده
Deferiprone and Exagamglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Deferiprone belongs to Miscellaneous; Exagamglogene autotemcel belongs to Miscellaneous.
چرا رخ می‌دهد
Myelosuppression from deferiprone may compromise stem cell collection and engraftment.
اقدام لازم
Discontinue deferiprone at least 7 days before mobilization and conditioning. Use a non-myelosuppressive alternative or phlebotomy if iron control is needed afterward.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Deferiprone و Exagamglogene autotemcel، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Deferiprone
تداخلات دیگر Exagamglogene autotemcel
پرسش‌های متداول
Can I take Deferiprone with Exagamglogene autotemcel?
MediHelp rates the interaction as major. Deferiprone and Exagamglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Iron chelators such as deferiprone can be myelosuppressive and may interfere with stem cell mobilization, conditioning and engraftment. Continuing deferiprone around these steps raises the risk of delayed hematologic recovery and infection.
How serious is the interaction between Deferiprone and Exagamglogene autotemcel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Discontinue deferiprone at least 7 days before mobilization and conditioning. Use a non-myelosuppressive alternative or phlebotomy if iron control is needed afterward.
What other medicines interact with Deferiprone?
MediHelp also lists interactions of Deferiprone with, for example, Clozapine, Abemaciclib, Acalabrutinib. The full list is on the Deferiprone page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
